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Peripheral blood mononuclear cells (PBMC) from humans without antibodies to dengue 2 virus lysed dengue
2 virus-infected Raji cells to a significantly greater degree than uninfected Raji cells. The addition of mouse
anti-dengue antibody increased the lysis of dengue-infected Raji cells by PBMC. Dengue 2 immune human sera
also increased lysis of dengue-infected Raji cells by PBMC. These results indicate that both PBMC-mediated
cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC) can cause significant lysis of dengue-
infected Raji cells. The lysis of infected Raji cells in the ADCC assay correlated with the dilution of dengue-
specific antibody which was added, indicating the dengue virus specificity of the lysis of dengue virus-infected
Raji cells. Alpha interferon (IFNa) was detected in the culture supernatant of PBMC and dengue-infected Raji
cells. However, enhanced lysis of dengue-infected Raji cells by PBMC may not be due to the IFN produced,
because neutralization of all IFN activity with anti-IFNa antibody did not decrease the lysis of dengue-infected
cells, and effector cells pretreated with exogenous IFNa also lysed dengue-infected cells to a greater degree than
uninfected cells. The effector cells responsible for lysis of dengue virus-infected Raji cells in the natural killer
and ADCC assays were analyzed. Nonadherent PBMC caused more lysis than did adherent cells. Characteriza-
tion of nonadherent cells with monoclonal antibodies showed that the predominant responsible effector cells
were contained in OKM1+ and OKT3- fraction in the natural killer and ADCC assays.
Dengue virus infection is a major worldwide cause of
morbidity (15), and hemorrhagic fever and shock are severe
and, at times, fatal complications of dengue infections (15).
These complications are more commonly observed in indi-
viduals undergoing a secondary dengue infection with a virus
of another dengue subtype than that which they had experi-
enced in their primary infection (16). These observations
indicate that the immune response of the host may play an
important role in the complications of dengue infection.
The mechanism of this apparent sensitization to subse-
quent dengue infections is not defined. One theory is that
antibody formed during the secondary response forms com-
plexes with viral antigen and that massive complement
activation follows the formation of this immune complex,
resulting in increased vascular permeability and initiating a
shock syndrome (26). Another theory postulates that im-
mune-mediated destruction of dengue-infected monocytes,
which are the most productive source of replicating virus
(17), is responsible for releasing various substances, includ-
ing C3b and unidentified vascular permeability factor(s),
from such monocytes (15). The complication of hemorrhagic
fever and shock make it important to understand the mecha-
nism of immunological sensitization and of elimination of
dengue-infected cells.
Dengue virus infection induces type-specific and cross-
type-reactive antibody responses (30). Infection results in
lifelong resistance to challenge with homologous virus; how-
ever, protection against heterologous strains is short-lived
(27, 28), and secondary infection may be more severe than
primary infection. At subneutralizing levels of antibody,
enhanced infection of cells with Fc receptors can be detected
in vitro (10). This effect has also been studied in vivo by the
passive transfer of antibody to infected monkeys which
resulted in enhanced replication of virus in circulating mono-
cytes (14). The role, however, of this antibody-enhanced
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replication of dengue virus infection is uncertain in the
dengue hemorrhage fever and shock syndrome. On the other
hand, antibody may help to eliminate dengue-infected cells.
Cytolysis of dengue-infected Vero cells by antibody-depen-
dent, complement-mediated cytolysis has been reported,
although the percent lysis of infected cells was low (8).
Antibody may also eliminate virus-infected cells by anti-
body-dependent, cell-mediated cytotoxicity (ADCC). ADCC
has been reported to lyse virus-infected cells in vitro (18, 23),
but its role in eliminating virus-infected cells in vivo has not
been defined. Other cell-mediated immune responses have
been found to be effective for the lysis of virus-infected cells
in vitro and may aid in eliminating viral infection in vivo.
These include macrophages (32), natural killer (NK) cells
(25), and cytotoxic T cells (11). These cellular effector
functions have not been analyzed in dengue virus infections.
The illness caused by dengue virus infections and its compli-
cations stimulated us to examine the cellular immune re-
sponses to dengue infection. In this paper, we describe the
lysis of dengue-infected Raji cells by PBMC active in the NK
and ADCC assays.
MATERIALS AND METHODS
Virus. Dengue virus type 2 (dengue 2 virus) New Guinea C
strain was supplied by the Walter Reed Army Institute of
Research. This virus was then propagated in mosquito cells
(c6/36). Briefly, mosquito cells were infected with dengue 2
virus at a multiplicity of infection of 0.1 PFU per cell and
incubated in Eagle minimal essential medium containing 2%
heat-inactivated fetal calf serum (FCS) and 0.8% bovine
serum albumin at 28°C for 7 days. The culture fluid was
stored as virus stock at -85°C until use. The infectious virus
titer was determined to be 1 x 107 PFU/ml by plaquing on
Vero cells with standard techniques (33).
Anti-dengue 2 antibody. Ascitic fluid from mice hyperim-
munized with dengue 2 virus was used for antibody (4). The
titer of this antibody was 1:256 by complement fixation test
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and 1:1,024 by neutralization tests. Hyperimmune ascitic
fluid was heated at 56°C for 30 min to destroy complement
activity before use.
Human sera. Human sera obtained from virus isolation-
documented cases of dengue 2 illness in Puerto Rico in 1968
were used as sources of anti-dengue 2 human antibody.
Human sera with or without antibody to Epstein-Barr virus
we:e supplied by T. Sairenji of the University of Massachus-
setts Medical School. These sera did not contain antibodies
to dengue virus. All human sera were heated at 56°C for 30
min before use.
Cell cultures. Raji cells (24), Raji cells persistently infected
with dengue 2 virus, and K562 cells (22) were used as the
targets in NK and ADCC assays. All cell lines were cultured
in RPMI 1640 medium (Flow Laboratories, McLean, Va.)
containing 10% FCS. Preparation of the dengue virus-infect-
ed Raji cells is described below. Theofilopoulos et al.
reported that Raji cells were persistently infected with
dengue 2 virus, and more than 70% of cells contained dengue
antigens (34).
Human PBMC. Peripheral blood specimens were obtained
from healthy donors who do not have antibodies to dengue
virus. PBMC were separated by the Ficoll-Hypaque density
gradient centrifugation method (3). Cells were suspended at
a concentration of 1 x 107 to 3 x 107/ml in RPMI 1640
containing 10% FCS and 10% dimethylsulfoxide (Fisher
Scientific Co., Pittsburgh, Pa.) and were cryo-preserved in
liquid nitrogen until use.
IFN assay. Interferon (IFN) was assessed by a cytopathic
effect reduction assay. Twofold serial dilution of IFN sam-
ples were incubated with human fibroblast cells for 20 h at
37°C and then challenged with vesicular stomatitis virus. An
international IFN standard was included in each assay, and
titers were read after 48 h at 37°C.
Neutralization of IFN. Neutralization of antiviral activity
was carried out by using specific antisera to human alpha,
beta, and gamma IFN. Antiserum to IFNcx was purchased
from Interferon Sciences, Inc., New Brunswick, N.J. Anti-
sera to IFNP and IFN-y were gifts from A. Meager, Division
of Virology, National Institute of Biological Standards and
Control, London. Diluted IFN samples containing 25 U/ml
were incubated for 2 h at room temperature with serial
dilutions of antiserum, and the residual IFN titers were
determined by the cytopathic effect reduction assay.
Pretreatment of effector cells with actinomycin D. Effector
cells (4 x 106/ml) were incubated with various concentra-
tions of actinomycin D (Sigma Chemical Co., St. Louis,
Mo.) at 37°C for 1 h. Cells were washed three times and then
were used as effectors.
Pretreatment of effector cells with IFNa. Effector cells (2 x
106/ml) were incubated with 1 x 104 U/ml of human IFNa
(Lee and Biomolecular Research Laboratories, San Diego,
Calif.) at 37°C for 4 h. Cells were washed three times and
then were used as effectors. Anti-IFNot antibody was added
to the NK assay at a final dilution of 1:10.
Immunofluorescence staining. Dengue 2 virus membrane
antigens were identified on infected Raji cells by indirect
membrane fluorescence. Cells (2 x 106) in 0.05 ml of
phosphate-buffered saline were incubated at 37°C for 30 min
with 0.1 ml of dengue 2-hyperimmunized mouse ascitic fluid
diluted to a concentration of 1:10. Cells were washed twice
and reacted with fluorescein isothiocyanate-conjugated
sheep anti-mouse immunoglobulin G (Cappel Laboratories,
Cochransville, Pa.) at 37°C for 30 min. Cells were again
washed twice, and the percentage of stained cells was
assessed with a fluorescent microscope.
To identify intracellular dengue 2 viral antigens, cells were
air-dried on slide glasses and fixed with acetone at -20°C for
10 min. The fixed cells were reacted with hyperimmunized
mouse ascitic fluid and fluorescein isothiocyanate-conjugat-
ed anti-mouse immuoglobulin G as described above. Raji
cells which were not infected with dengue 2 virus were
always included as controls. They showed no fluorescence
with the anti-dengue 2 sera in either the membrane or fixed-
cell preparations.
Cell separation. Adherent cells were separated from
PBMC with FCS-coated plastic petri dishes (Becton-Dickin-
son Labware, Oxnard, Calif.) as previously described (20).
For separation of nonadherent cells, adherent cells were
depleted from PBMC by adherence to plastic dishes (1). The
percentage of PBMC contained in each fraction was 96% in
the adherent fraction and 3% in the nonadherent fraction as
determined by yeast ingestion (20).
Nonadherent cells were stained at 4°C by indirect mem-
brane immunofluorescence with monoclonal OKM1 and
OKT3 antibodies (Ortho Pharmaceutical Corp., Raritan,
N.J.) and fluorescein isothiocyanate-conjungated sheep anti-
mouse immunoglobulin G was used as secondary antibody.
Stained lymphocytes were sorted with a fluorescence-acti-
vated cell sorter (FACS 440; Becton-Dickinson Co., Moun-
tain View, Calif.).
NK and ADCC assays. Target cells (1 x 106 to 5 x 106
cells) were labeled with 0.5 mCi of 51Cr(Na2CrO4) (New
England Nuclear Corp., Boston, Mass.) in 0.5 ml of RPMI-
10% FCS at 37°C for 90 min. Labeled cells were washed
twice and suspended in RPMI-10% FCS. Labeled cells (104)
in 0.1 ml were added to each well in round-bottom microtiter
plates (Limbro Scientific, Hamden, Conn.). Medium con-
taining anti-dengue 2 antibody (for the ADCC assay) or
lacking this antibody (for the NK assay) was added in 0.05-
ml volumes to each well and cultured at 37°C for 30 min.
Various concentrations of effector cells were added in 0.05
ml of medium to each well to give the described effector/tar-
get (E/T) ratios. After incubation at 37°C for 16 to 18 h, 0.1
ml of supernatant fluid was collected from each well and
counted in an automatic gamma counter. Quadruplicate
samples were tested. Spontaneous release from dengue-
infected and uninfected Raji cells was ca. 20% of maximum
release.
The percent specific 51Cr release was calculated as fol-
lows: (counts per minute [cpm] experimental release - cpm
spontaneous release/cpm maximal release - cpm spontane-
ous release) x 100.
Statistical analysis. The significance of differences between
values was examined by the Student t test, paired t test, or
Wilcoxon rank sum test. Differences yielding P values of
<0.05 were regarded as significant.
RESULTS
Preparation of Raji cells persistently infected with dengue 2
virus as infected target cells. Raji cells were infected with
dengue 2 virus at a multiplicity of infection of 0.05 PFU per
cell at 37°C for 2 h. Infected cells were washed twice with
RPMI, suspended at the concentration of 2 x 105 cells per ml
in RPMI-10% FCS and cultured at 37°C in 5% CO2. The cells
were suspended in fresh medium (RPMI-10% FCS) at the
concentration of 2 x 105 cells per ml every 3 days. At day 7
after infection, 40% of the cells were positive, and by day 9,
90% were positive for dengue membrane and cytoplasmic
antigens. These cells are split every 3 days at a ratio of 1:10
and have remained infected over 9 months, with more than
90% expressing membrane and cytoplasmic dengue anti-
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gens. The cells in this persistently infected culture line are
more than 95% viable as determined by dye exclusion testing
with trypan blue. The dengue virus titer of supernatant
culture fluids is 3 x 103 PFU/ml, and the IFN titer is 3 U/ml.
These persistently infected Raji cells were used as target
cells in the following studies.
Lysis of dengue 2-infected Raji cells by PBMC with or
without anti-dengue 2 antibody. Dengue 2-infected Raji cells
and uninfected Raji cells were used as target cells with
normal human PBMC as effector cells. These PBMC had
been obtained from healthy donors who did not have anti-
bodies to dengue virus. Table 1 shows the results of an 18-h
51Cr release assay, with or without hyperimmune anti-
dengue 2 ascitic fluid. Dengue-infected Raji cells were lysed
by PBMC without antibody more than uninfected Raji cells
(P < 0.01). The addition of anti-dengue 2 antibody signifi-
cantly increased the lysis by PMBC of dengue 2-infected
cells (P < 0.0025) but did not increase the lysis of uninfected
Raji cells. Ascitic fluid from nonimmunized mice caused no
augmentation of the lysis of dengue-infected or uninfected
cells at a 1:20 dilution (data not shown).
PBMC also lysed acutely infected Raji cells to a greater
degree than uninfected Raji cells on day 5 after infection
(percent specific lysis was 18% from infected cells and 3%
from uninfected cells with one donor, 10% from infected
cells and 2% from uninfected cells with the other donor).
These results indicate that PBMC lyse dengue-infected Raji
cells significantly more than uninfected Raji cells and that
the augmentation of PBMC-mediated killing by anti-dengue
antibody was detected on dengue-infected target cells but
not on the uninfected target cells. In general, there is a
statistically significant correlation between the percent lysis
of K562 cells and that of dengue-infected cells in the NK
assay (r = 0.77; P < 0.01); however, the PBMC of some
individuals which lyse K562 cells do not lyse dengue-
infected cells very well.
Time course and effector-target dose-response studies of the
lysis of dengue-infected Raji cells by PBMC and ADCC.
Experiments were carried out to determine the time course
of lysis of dengue-infected or uninfected Raji cells by PBMC
with or without anti-dengue 2 antibody. PBMC from two
donors were incubated with target cells at the E/T ratio of 50
(with effector no. 2) and 10 (with effector no. 8) for various
numbers of hours (Fig. 1). The specific lysis by PBMC of
dengue 2-infected Raji cells reached a maximum at 8 to 18 h
of incubation, depending on the effector used. Specific lysis
of infected cells by ADCC (percent 5 Cr release from infect-
ed cells by ADCC minus percent 5 Cr release from infected
cells by PBMC without antibody) reached a maximum by 18
h of incubation.
The dose-response effect of various E/T ratios was evalu-
ated with the same two donor cells as effectors (Table 2).
There was an obvious dose-response relationship between
the E/T ratio and specific 51Cr release from the target in both
the NK (PBMC alone) and the ADCC assays.
The results of these two experiments also confirmed the
results described in Table 1; i.e., at any time of incubation,
and at any E/T ratio studied, dengue-infected cells were
lysed by PBMC to a greater degree than uninfected cells, and
the addition of anti-dengue antibody augmented the lysis by
PBMC of dengue-infected cells.
Dose-response relationship between the anti-dengue 2 anti-
body and the specific increase of lysis by ADCC. Hyperim-
mune ascitic fluid was used as antibody and was diluted from
1:10 to 1:1.5 x 105, and the PBMC from donors no. 2 and no.
8 were used as effector cells (Fig. 2). There was a dose-
response relationship between the added antibody and the
specific 5'Cr release by ADCC when hyperimmune ascitic
fluid was used.
ADCC lysis of dengue-infected Raji cells with human anti-
dengue 2 sera. We used several human sera as the source of
antibody in ADCC assays. These sera included four positive
and four negative sera for anti-dengue 2 antibody (Table 3).
Pooled human AB serum, which we used as a control, did
not increase lysis by PBMC of dengue 2-infected and unin-
fected Raji cells in previous experiments (data not shown).
The addition of antisera containing antibody to dengue 2
virus increased the lysis of dengue 2-infected cells signifi-
cantly more than the lysis of uninfected cells (P < 0.025).
The addition of sera without anti-dengue 2 antibodies, how-
ever, did not increase the lysis of infected cells. This
experiment with human sera confirmed the results of earlier
experiments with murine antibodies and human effector
cells. Serum positive for anti-Epstein-Barr virus antibody
TABLE 1. Lysis of dengue 2 virus-infected Raji cells by PBMC and antibody
% Specific 5'Cr release'
Effector Infected Raji' Uninfected Raji'
- Antibodyd + Antibodyb - Antibodyd + Antibody
1 14.6 7.7 30.5 5.3 1.7
2 37.6 8.6 29.4 7.8 7.3
3 47.6 18.1 16.5 4.0 7.1
4 31.6 4.4 10.0 0.4 4.0
5 33.6 13.4 ND 2.6 ND
6 45.1 6.1 14.6 1.6 7.3
7 38.8 0.1 10.2 3.2 3.2
8 72.3 37.4 55.1 28.3 29.5
9 33.1 2.4 16.5 1.3 3.6
10 ND 16.6 24.1 2.3 5.7
Mean 39.4 11.5 23.0 5.7 7.7
a Percent specific 51Cr release from dengue 2-infected and uninfected cells after 18-h assay. ND, Not determined.
b Ascitic fluid from dengue 2-hyperimmunized mice was used as a source of anti-dengue 2 antibody at a 1:20 dilution.
c Significance was determined by paired t test between the lysis of target cells by PBMC with and without antibody (P < 0.0025 for infected Raji cells, not
significant for uninfected Raji cells).
d Significance was determined by paired t test between the lysis of infected Raji cells without antibody and that of uninfected Raji cells without antibody (P <
0.01).
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FIG. 1. Time course study of the lysis of dengue 2-infected or
uninfected Raji cells in NK and ADCC assays. The percent specific
5tCr release from target cells in NK and ADCC assays was assessed
after the indicated hours of incubation. Hyperimmune mouse ascitic
fluid was used at a 1:20 dilution in the ADCC assay. The E/T ratio
was 50:1 with donor no. 2 (Fig. la) and 10:1 with donor no. 8 (Fig.
lb). Symbols: 0, infected Raji cells without antibody (NK assay);
*, infected Raji cells with antibody (ADCC assay); A, Uninfected
Raji cells without antibody (NK assay).
but negative for anti-dengue 2 antibody did not augment the
lysis of dengue-infected Raji cells. Therefore, the killing of
dengue-infected Raji cells was not due to their being Epstein-
Barr virus-transformed cells.
Production of IFN during NK and ADCC assays of dengue-
infected Raji cells. We assessed whether IFN was produced
during these assays to determine whether IFN may have
contributed to the enhanced lysis of dengue-infected Raji
cells by PBMC (Table 4). High titers of IFN (1,600 U/ml)
were detected only in the culture supernatants containing
both PBMC and dengue-infected Raji cells. The same titer of
IFN was also detected in the ADCC assay. However, only 6
U of IFN per ml was detected in the culture supernatant of
PBMC and uninfected Raji cells. The IFN was characterized
as alpha because it was neutralized by specific antisera to
human IFNa but not by antisera to IFNP and IFNy.
Addition of anti-IFNa antibody and pretreatment of effector
cells with actinomycin D or IFNa. We examined the effects of
anti-IFNa antibody on the lysis of dengue-infected Raji cells
in the NK assay (Table 5). We added various dilutions of
anti-IFNa antibody to the NK assay and assessed the
specific lysis and IFN titer in the culture supernatant at 18 h.
Although the addition of anti-IFNa antibody diluted to a
concentration of 1:40 neutralized all detectable IFN pro-
duced during the NK assay, the specific lysis of dengue-
infected Raji cells did not decrease, suggesting that the
presence of IFN throughout the assay was not required to
demonstrate the increased lysis of dengue-infected cells.
To study the possible early contribution of IFN to the
enhanced killing of dengue-infected cells, we pretreated the
effector cells with 0.02 to 0.16 ,ug of actinomycin D per ml
(Table 6). Although pretreatment of effector cells in actino-
mycin D decreased the production of IFN by 50 to 75%, the
specific lysis of dengue-infected cells did not concomitantly
decrease. Pretreatment of effector cells with 0.02 to 0.16 p.g
of actinomycin D per ml did not decrease the lysis of
uninfected cells either (data not shown).
In addition, we pretreated the effector cells with 104 U of
exogenous human IFNa per ml. Pretreatment of effector
cells with IFNa increased proportionally the lysis of dengue-
infected and uninfected Raji cells; i.e., 53% augmented lysis
of dengue-infected Raji cells, and 60% augmented lysis of
uninfected Raji cells. Effector cells pretreated with IFNct
lysed dengue-infected cells to a greater degree than uninfect-
ed cells, as did untreated effector cells (data not shown).
This result and those shown in Tables 5 and 6 appear to
indicate that the enhanced lysis of dengue-infected cells by
TABLE 2. Effector-target cell dose-response study in the lysis of dengue 2 virus-infected cells in NK and ADCC assays
% Specific 5'Cr release from target cells'
Effector no. 2 Effector no. 8
EtT ratio Infected Raji Uninfected Infected Rajib Uninfected
ADCCc NK Raji (NK) ADCC' NK Raji (NK)
100 41.2 26.1 11.8 ND ND ND
50 32.5 26.9 10.7 64.2 48.3 38.4
25 25.9 19.7 7.1 58.7 39.6 32.9
12.5 18.9 14.5 6.6 45.9 33.7 25.1
6.3 11.8 7.9 6.0 33.6 26.8 17.5
3.2 6.1 1.7 1.6 19.4 17.2 8.9
1.6 ND ND ND 26.7 19.4 6.2
a Percent specific 5"Cr release from dengue 2-infected Raji cells after 18-h assay. ND, Not determined.
b Significance was determined by the Wilcoxon rank sum test between ADCC lysis of infected Raji cells and NK lysis of infected Raji cells (P = 0.025 for both
no. 2 and no. 8) and between NK lysis of infected Raji cells and NK lysis of uninfected Raji cells (P = 0.025 for both no. 2 and no. 8).
c Hyperimmune mouse ascitic fluid was used at a 1:10 dilution in ADCC assay.
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FIG. 2. Dose-response relation between the dose of antibody
added and the lysis of infected Raji cells by ADCC. Percent specific
5"Cr release from dengue 2-infected Raji cells by ADCC was
assessed after 18 h of incubation. Hyperimmune mouse ascitic fluid
was used at 1:10 to 1:156,250 dilution. The E/T ratio was 50:1 with
donor no. 2 and 10:1 with no. 8. Ab, Antibody.
PBMC may not be due to the IFN produced during the
assay.
Effector cells responsible for lysis of dengue-infected target
cells in NK and ADCC assay. We initially assessed the nature
of the effector cells responsible for killing dengue-infected
target cells with or without anti-dengue 2 antibody, using
adherent and nonadherent cells from PBMC (Table 7). The
results showed that the predominant cells responsible for the
lysis of dengue-infected Raji cells in NK and ADCC assays
were nonadherent cells, although some lysis was associated
with the adherent cells.
We then analyzed in more detail the nature of the nonad-
herent cytotoxic cells, using monoclonal antibodies to the
Ml and T3 antigens. Nonadherent PBMC were reacted with
monoclonal antibodies to Ml or T3 antigens and sorted for
use as effector cells in NK and ADCC assays (Table 8). In
the NK assay, OKM1+ cells caused higher lysis of dengue-
infected Raji cells than OKM1- cells (P < 0.001). However,
OKT3+ and OKT3- cells lysed dengue-infected Raji cells to
almost the same degree. In the ADCC assay, OKM1+ cells
also caused a significantly higher level of lysis (P < 0.001),
although some level of lysis was observed with OKM1-
cells. OKT3- cells caused a higher level of lysis than did
OKT3+ cells. K562 cells, which are used as target cells for
assaying human NK cells, were lysed by OKM1+ and
OKT3- cells but not by OKM1- and OKT3+ cells. These
results indicated that the nonadherent effector cell(s) respon-
sible for lysis of dengue-infected cells are contained in the
OKM1+ fraction and in both OKT3- and OKT3+ fractions
in the NK assay and are contained in OKM1+ and OKT3-
fractions in the ADCC assay. Therefore, some of the effector
cells responsible for killing dengue-infected Raji cells include
some cells of a different phenotye than the NK cells respon-
sible for lysis of K562 cells, which are OKM1+ and OKT3-.
DISCUSSION
In these studies, we have shown that PBMC-mediated
cytotoxicity and ADCC effectively kill dengue virus-infected
cells in vitro. This conclusion is based on the following
results. (i) PBMC from donors without antibodies to dengue
2 virus lysed dengue 2-infected Raji cells significantly better
than uninfected Raji cells. (ii) The addition of murine or
human anti-dengue 2 antibody into the NK assay increased
the lysis of dengue-infected cells but did not increase the
lysis of uninfected cells. The addition of ascitic fluid from
unimmunized mice did not increase the lysis of dengue-
infected cells. (iii) There was a dose-response relationship
between the level of anti-dengue 2 antibody added and the
specific 5tCr release of ADCC, indicating the dengue virus
specificity of the lysis of dengue-infected cells.
We have also detected increased lysis by PBMC of Raji
cells infected with another subtype of dengue virus. PBMC
lysed Raji cells persistently infected with dengue 4 virus to a
higher level than uninfected Raji cells, and the addition of
anti-dengue 4 antibody further increased the lysis of PBMC
of dengue 4-infected Raji cells (unpublished data).
TABLE 3. Lysis of dengue 2 virus-infected Raji cells by ADCC, using human sera as antibody sources
% Specific 5"Cr release"
Human sera
(neutralizing antibody titer)b Infected Raji' Uninfected Raji'
ADCC Axd ADCC Ax
Anti-dengue 2 antibody positive
1 (640) 29.4 14.6 9.5 3.8
2 (640) 21.8 7.0 10.4 4.7
3 (160) 27.1 12.3 11.9 6.2
4 (80) 25.1 10.3 8.0 2.3
Anti-dengue 2 antibody negative
1 13.8 -1.0 4.1 -1.6
2 15.3 0.5 4.5 -1.2
3 Control AB serum 14.8 0 5.7 0
Anti-EBV antibody
4 Antibody + 13.6 -1.2 4.6 -1.1
5 Antibody - 11.2 -3.6 2.8 -2.9
a Percent specific 51Cr release from dengue 2-infected and uninfected Raji cells after 18-h assay.
b Human sera were used at a 1:10 dilution after inactivation of complement. The neutralizing antibody titers in the human sera are described in parenthesis.
c Significance was determined by paired t test between Ax of infected Raji cells and Ax of uninfected Raji cells in the assay using sera positive for anti-dengue 2
antibody (P < 0.025).
d AX, Percent specific lysis of target cells minus percent specific lysis by ADCC with control AB serum.
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TABLE 4. Quantitation of IFN in culture superantants of effector
cells and dengue virus-infected Raji cells
Effeto Anti-den- IFNbTarget cells ector gue 2' (U/ml) Specific
antibody lysis
Dengue 2-infected + + 1,600 45.5
Raji
+ - 1,600 32.1
_
- <6 0
Uninfected Raji + - 6 18.8
- - <6 0
None + - <6 C
a Hyperimmune mouse ascitic fluid was used at a 1:20 dilution.
b Effector cells and target cells were cultured at an E/T ratio of 50:1 for 18 h,
and IFN in the culture supernatants was quantitated.
c
-, No value due to lack of target cells.
There is a statistically significant correlation in the specific
lysis by PBMC between K562 cells and dengue-infected
cells. However, there is a relatively high heterogeneity as to
the lytic activity of PBMC against dengue-infected cells, and
some effector cells which lyse K562 to an average level lyse
dengue-infected cells to a low level.
We have characterized the cells responsible for the lysis of
dengue 2-infected Raji cells, using monoclonal antibodies to
Ml and T3. Our results were as follows: effector cells
responsible for the lysis of dengue-infected Raji cells in NK
assay are contained in the OKM1+ cells and in both OKT3+
and OKT3 cells, effector cells in ADCC assay are con-
tained in OKM1+ and OKT3 cells. In the same experi-
ments, K562 cells, which are usually used as target cells for
human NK assay, were lysed very well by nonadherent cells
contained in OKM1+ and OKT3 fractions but not by cells
contained in the OKT3+ fraction. These results as well as
the different level of lysis by PBMC of K562 and dengue-
infected cells indicate that some of the effector cells respon-
sible for lysis of dengue-infected cells are different cells from
those responsible for lysis of K562. Heterogeneity of NK
cells has been reported in human systems (12). Lopez has
noted that the human NK cells killing K562 and herpes
simplex virus type 1 (HSV-1)-infected target cells have
somewhat different characteristics, although both cell types
appear within the larger granular lymphocyte population
(12). Our results with dengue virus-infected cells are consis-
tent with these previous reports.
Little is known about the characteristics of effector cells
responsible for ADCC to virus-infected cells. Some reports
showed that null cells and T cells are effector cells in the
ADCC assay for virus-infected cells, and both cell types
TABLE 5. Effect of anti-IFN antibody on the lysis of Dengue
virus-infected Raji cells by PBMC
Serum Dilution IFN (U/ml % Specific
added Diuin IN Um)lySiSb
None 400 (25)' 36.9 (13.0)'
Anti-IFNa 1:40 <25 (<25) 31.5 (13.0)
1:160 100 (<25) 36.0 (15.8)
Control 1:40 200 (<25) 35.1 (15.0)
1:160 400 (50) 31.8 (13.7)
a Dilutions of anti-IFN antibody were added to wells in the NK assay. IFN
in the culture supernatant was quantitated after 18 h of culture.
b E/T ratio was 40:1.
' Numbers in parentheses indicate results obtained by using uninfected Raji
cells as target cells.
TABLE 6. Effect of actinomycin D on the lysis of dengue virus-
infected cells by PBMC and IFN production
Actinomycin Da % Specific' IFNb
(p.g/ml) lysis (U/ml)
0 31.8 1,600
0.02 31.8 800
0.04 31.1 800
0.08 27.7 800
0.16 27.7 400
a Pretreatment of effector cells with actinomycin D is described in the text.
b Effector and target cells were cultured at an E/T ratio of 50:1 for 18 h.
have human NK (HNK-1) antigen, using respiratory syncy-
tial virus- and influenza virus-infected targets (18, 23). In our
experiments, T cells (OKT3+ cells) were not responsible for
ADCC of dengue-infected cells. We do not know whether
this difference is due to the virus used, the methods of
separating cells, or for some other reasons. Our studies with
other monoclonal antibodies indicate that the effector cells
responsible for lysis of dengue-infected cells in the NK and
ADCC assays are contained in the Leull+ and Leu7-
fraction, but some activity is in the Leull- and Leu7+
fraction (unpublished data). Further characterization of the
effector cells is in progress.
There are reports with several other viruses that infected
cells are lysed by NK cells to a greater degree than uninfect-
ed target cells (6, 9). However, the mechanism of enhanced
lysis of virus-infected cells is not clearly known. In some
cases, IFN is thought to be a prominent cause of enhanced
lysis of infected cells. That is, NK cells which were activated
by virus-induced IFN during the NK assay are thought to
cause the enhanced killing of infected cells (29). We detected
>400 U of IFNot per ml in the culture supernatants ofPBMC
and dengue-infected cells. However, the addition of anti-
IFNa antibody, which neutralized all IFN produced during
the assay, did not decrease the specific lysis of infected Raji
cells by PBMC. Pretreatment of effector cells with actinomy-
cin D, which decreased IFN production, did not decrease
the lysis of dengue-infected cells. Dengue-infected cells were
also lysed to a greater degree than uninfected cells by IFN-
pretreated effector cells as when effector cells were not
pretreated with IFN. These results suggest that the en-
TABLE 7. Lysis of dengue-infected Raji cells by adherent and
nonadherent cells with or without anti-dengue 2 virus antibody
% Specific 5'Cr releaseb
Effector cells' E/T Infected Raji Uninfected K562
ratio Raji (-nioy+ Antibody" -Antibody (- antibody) (-antibody)
Unfractionated 50 ND 55.4 43.9 73.7
PBMC 10 47.7 31.7 19.1 33.0
Adherent cells 50 ND 35.3* 16.7 15.0O
10 25.5* 16.4*** 7.4 10.0'1
Nonadherent 50 ND 51.7* 26.6 75.5'
cells 10 46.6* 37.0*** 18.4 38.8"
a Percentage of phagocytic cells contained in each fraction: unfractionated,
15%; adherent, 96%; and nonadherent, 3%.
b Percent specific "Cr release from each target after 16 h of assay.
Significance was determined for the difference in the level of lysis between
groups with the same symbol: , P < 0.001; ", P < 0.0025, **, P <0.001,t,
P < 0.001, tt, p < 0.001.
' Hyperimmune mouse ascitic fluid was used at 1:10 dilution. ND, Not
done.
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TABLE 8. Lysis of dengue virus-infected Raji cells by effector
cells sorted with OKM1 or OKT3 antibody
% Specific 51Cr releaseb
Effector cells" Infected Raji Uninfected K562
+ Anti- - Anti- Raji (-anti-
body' body (-antibody) body)
Expt 1
Unfractionated PBL 17.0 11.3 2.4 4.2
OKM1+ 24.1 20.9* 5.1 26.3*
OKM1- 9.1* 3.1 1.1 1.1
Expt 2
Unfractionated PBL 24.6 20.1 4.5 8.5
OKT3+ 14.2' 15.5tt 1.2 0.8ttt
OKT3- 25.9t 18.4't 4.7 33.3ttt
a Percentage of OKM1+ cells was 16% in unfractionated, 96% in OKM1+,
and 2% in OKM1- fraction. Percentage of OKT3+ cells was 78% in unfrac-
tionated, 99% in OKT3+, and 2% in OKT3- fraction.
b Percent specific 5"Cr release after 16-h assay. The E/T ratio was 10.
Significance was determined by Student's t test. *, P < 0.001; **, P < 0.001;
0.0025; t, P < 0.001; tt, Not significant, ttt, P < 0.001.
'Hyperimmune mouse ascitic fluid was used at a 1:20 dilution.
hanced lysis of dengue-infected Raji cells by PBMC may not
be due to the INF produced during assay. These results are
consistent with reports that natural killing of HSV-1-infected
target cells is dissociated from the induction of IFN (2, 13).
Other possible explanations of the enhanced lysis of virus-
infected cells include: (i) enhanced adhesion of NK cells to
virus-infected targets due to glycoproteins or to virus-in-
duced cellular receptors (35), (ii) impairment of infected cells
to repair damaged membranes (12), or (iii) an activation of
NK cells via viral glycoproteins (7). The mechanism which is
responsible for the enhanced lysis of dengue-infected cells
by PBMC remains to be elucidated.
Despite the evidence that virus-infected targets are lysed
more than uninfected targets by NK and ADCC in vitro (9,
23), there is relatively little information available on the in
vivo significance of these cells in virus infection. Mice
deprived of NK activity by the injection of anti-asialo GM1
antibody are more susceptible to murine cytomegalovirus,
mouse hepatitis virus, and vaccinia virus (5). Beige mice,
which have very low NK activity, are also very sensitive to
murine cytomegalovirus infection (31). In a study designed
to analyze the contribution ofADCC in HSV infection, mice
were irradiated and then injected with human peripheral
blood lymphocytes and anti-HSV antibody. These mice
were reported to be more resistant to HSV infection than
mice injected with only human peripheral blood lympho-
cytes or anti-HSV antibody (19).
This is the first report which demonstrates increased lysis
of dengue-infected cells by PBMC in vitro in NK and ADCC
assays. Many questions remain to be answered concerning
the role of NK and ADCC in dengue infections. What is the
role of NK and ADCC in the lysis of dengue-infected human
monocytes? Monocytes are the source of replicating virus in
humans and are hypothesized to release various mediators
leading to dengue shock syndrome (15). What is the virus-
antigenic specificity of killing by ADCC? Epidemiologically,
it is reported that infection with a different subtype of virus
from the primary one is more likely to cause the dengue
shock syndrome (16); therefore, a cross-reactive antigen
may be involved. These studies should lead us to a better
understanding of dengue infection and eventually to prevent
the dengue shock syndrome.
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